Kiniksa Pharmaceuticals International, plc (KNSA)

SEC filing

Kiniksa Pharmaceuticals International, plc

KNSA · CIK 1730430

4 · Apr 3, 2026 · Megna Michael R exercised options for 7,564 shares; was granted 372 shares at $24.16/share ($8,988); reported 3,205 shares

Megna Michael R exercised options for 7,564 shares; was granted 372 shares at $24.16/share ($8,988); reported 3,205 shares

xslF345X06/form4-04032026_080430.xml

xslF345X06/form4-04032026_080430.xmlSEC.gov

Graphics and non-inline formats (not embedded below).